According to the Zhitong Finance App, Sinopharm Holdings (01099.HK) announced results for the nine months ended September 30, 2026. The group achieved operating income of 427.613 billion yuan during the period, a year-on-year decrease of 0.9%; net profit attributable to owners of the parent company was 5.314 billion yuan, an increase of 0.13% over the previous year; and basic income per share was 1.7 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.